Concepedia

Publication | Open Access

High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia

DOIFull Paper Access

31

Citations

45

References

2017

Year

Gangzhi Zhu, Yonglong Yang, Yanjiao Zhang, Wei Liu, Mu-Peng Li, Wenjing Zeng, Xielan Zhao, Xiaoping Chen
Cellular Physiology and Biochemistry

Abstract

Our findings suggest that AHSP, EPB42, GYPC and HEMGN may be suitable biomarkers for diagnostic or therapeutic strategies for FLT3-ITD-positive AML patients.

References

YearCitations

Page 1